KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $412.0 million.

  • Bausch Health Companies' Interest Expenses rose 1907.51% to $412.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 919.38%. This contributed to the annual value of $1.4 billion for FY2024, which is 451.81% up from last year.
  • As of Q3 2025, Bausch Health Companies' Interest Expenses stood at $412.0 million, which was up 1907.51% from $465.0 million recorded in Q2 2025.
  • Bausch Health Companies' Interest Expenses' 5-year high stood at $465.0 million during Q2 2025, with a 5-year trough of $307.0 million in Q4 2022.
  • Moreover, its 5-year median value for Interest Expenses was $351.0 million (2021), whereas its average is $358.6 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first crashed by 2219.51% in 2023, then surged by 3285.71% in 2025.
  • Bausch Health Companies' Interest Expenses (Quarter) stood at $343.0 million in 2021, then fell by 10.5% to $307.0 million in 2022, then grew by 18.24% to $363.0 million in 2023, then dropped by 7.16% to $337.0 million in 2024, then increased by 22.26% to $412.0 million in 2025.
  • Its last three reported values are $412.0 million in Q3 2025, $465.0 million for Q2 2025, and $330.0 million during Q1 2025.